Literature DB >> 28113022

Second-Line Combination Therapies in Pancreatic Cancer: Where Are We Now?

Mario Uccello1, Michele Moschetta1, Hendrik-Tobias Arkenau1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28113022     DOI： 10.1200/JCO.2016.71.0921

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

Review 1.  Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA).

Authors:  M Uccello; M Moschetta; G Mak; T Alam; C Murias Henriquez; H-T Arkenau
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.